Top compounds associated with response to TMEM59L


Feature Type Standardized
Nominal ANOVA
mRNA tacrolimus CTRPv2 pan-cancer AAC 0.037 0.3
mRNA QL-X-138 GDSC1000 pan-cancer AAC 0.032 0.3
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.054 0.3
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.037 0.3
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.037 0.3
mRNA Crizotinib CCLE pan-cancer AAC 0.044 0.3
mRNA BMS-754807 FIMM pan-cancer AAC -0.13 0.3
mRNA KU-55933 GDSC1000 pan-cancer AAC -0.037 0.3
mRNA XL765 CTRPv2 pan-cancer AAC 0.038 0.3
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.3
Download CSV